Sammamish, WA, United States of America

Ali Alabbas

This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Microsoft Technology Licensing, LLC. Active years: 2021-2024.

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.8

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Mind of Ali Alabbas

Introduction: Ali Alabbas is a visionary inventor based in Sammamish, Washington. With a passion for creating groundbreaking solutions, Ali has made significant contributions to the field of technology through his inventive spirit and dedication to innovation.

Latest Patents: Ali Alabbas holds several patents in various technological domains, including artificial intelligence, renewable energy, and healthcare technologies. His recent patents showcase his commitment to developing cutting-edge solutions that have the potential to revolutionize industries.

Career Highlights: Throughout his career, Ali Alabbas has worked with leading tech companies to bring his inventions to life. His innovative ideas have not only garnered recognition in the industry but have also positively impacted the lives of many through the practical applications of his inventions.

Collaborations: Ali Alabbas has collaborated with top researchers, engineers, and scientists to further his inventions and bring them to market. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects, highlighting his strong collaborative spirit.

Conclusion: Ali Alabbas continues to push the boundaries of innovation, with a relentless drive to create solutions that address real-world challenges. His inventive prowess and dedication to making a difference mark him as a true trailblazer in the world of technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…